Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
85
NCT01045018
A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2008
Completion: Aug 31, 2009
NCT06541184
Ziconotide for Non-cancer Pain by Intrathecal Administration
Phase: N/A
Start: Oct 30, 2024
Completion: Oct 30, 2029